The findings indicate that the abnormally high expression of UBE2S is associated with more malignant gliomas and PTEN mutations, while a negative correlation was observed between UBE2S expression and 1p19q deletion and IDH1 mutations. The gene discussed is UBE2S; the disease is malignant glioma.